Back to Newsroom

Corbus Pharmaceuticals to Present at the 14th Annual BIO Investor Forum

Presentation With Live Webcast on October 21, 2015 at 11:30 a.m. PDT / 2:30 p.m. EDT

NORWOOD, MA — (Marketwired) — 10/13/15 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases, announced today that the Company’s Chief Executive Officer, Yuval Cohen, Ph.D., will be presenting at the 14th Annual BIO Investor Forum on Wednesday, October 21, 2015 at 11:30 a.m. Pacific Time at the Parc 55 in San Francisco, California.

Click here to read more